Edwards Lifesciences CorporationEWNYSE
Loading
EBITDA Over TimeContracting
Percentile Rank71
3Y CAGR-10.0%
5Y CAGR+5.9%
Year-over-Year Change
Earnings before interest, taxes, depreciation, and amortization
3Y CAGR
-10.0%/yr
vs +22.4%/yr prior
5Y CAGR
+5.9%/yr
Recent deceleration
Acceleration
-32.4pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $1.43B | -17.0% |
| 2024 | $1.72B | +12.3% |
| 2023 | $1.53B | -21.7% |
| 2022 | $1.96B | +3.7% |
| 2021 | $1.89B | +75.9% |
| 2020 | $1.07B | -17.9% |
| 2019 | $1.31B | +50.0% |
| 2018 | $872.20M | -23.5% |
| 2017 | $1.14B | +37.8% |
| 2016 | $827.10M | - |